Comparative risk of cerebral venous sinus thrombosis (CVST) following COVID-19 vaccination or infection: A national cohort study using linked electronic health records

References

• Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):1–11. doi:10.1056/NEJMoa2034577.
   PubMed Web of Science ®Google Scholar
• Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–16. doi:10.1056/NEJMoa2035389.
   PubMed Web of Science ®Google Scholar
• Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE. Safety and efficacy of the ChAdox1 nCov-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111. doi:10.1016/S0140-6736(20)32661-1.
   PubMed Web of Science ®Google Scholar
• Voysey M, Costa Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdox1 nCov-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021;397(10277):881–91. doi:10.1016/S0140-6736(21)00432-3.
   PubMed Web of Science ®Google Scholar
• Bernal JL, Andrews N, Gower C, Stowe J, Robertson C, Tessier E, Simmons, R, Cottrell, S, Roberts, R, O'Doherty, M, et al. Early effectiveness of COVID19 vaccination with BNT162b2 mRNA vaccine and ChAdox1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England. medRxiv. 2021. doi:10.1101/2021.03.01.21252652.
   Google Scholar
• Vasileiou E, Simpson CR, Shi T, Kerr S, Agrawal U, Akbari A, Bedston S, Beggs J, Bradley D, Chuter A. Interim findings from first dose mass COVID-19 vaccination rollout and COVID-19 hospitalisations in Scotland: national prospective cohort study of 5.4 million people. Lancet. 2021;397(10285):1646–57. doi:10.1016/S0140-6736(21)00677-2.
   PubMed Web of Science ®Google Scholar
• Covid-19 vaccines guidance. [accessed 2022 March 29th]. https://gov.wales/covid-19-vaccines.
   Google Scholar
• World Health organisation (2021), Adverse Events Following Immunization (AEFI). [ accessed 2022 Mar 29th]. https://www.who.int/teams/regulation-prequalification/regulation-and-safety/pharmacovigilance/health-professionals-info/aefi.
   Google Scholar
• Schultz NH, Sørvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, Wiedmann M, Aamodt A-H, Skattør TH, Tjønnfjord GE, et al. Thrombosis and thrombocytopenia after ChAdox1 nCov-19 vaccination. N Engl J Med. 2021 Jun 3;384(22):2124–30. doi:10.1056/NEJMoa2104882. Epub 2021 Apr 9. PMID: 33835768; PMCID: PMC8112568.
   PubMed Web of Science ®Google Scholar
• Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdox1 nCov-19 vaccination. N Engl J Med. 2021 Jun 3;384(22):2092–101. doi:10.1056/NEJMoa2104840. Epub 2021 Apr 9. PMID: 33835769; PMCID: PMC8095372.
   PubMed Web of Science ®Google Scholar
• See I, Su JR, Lale A, Woo EJ, Guh AY, Shimabukuro TT, Streiff MB, Rao AK, Wheeler AP, Beavers SF. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021. JAMA. 2021;325(24):2448–56. doi:10.1001/jama.2021.7517. PMID: 33929487.
   PubMed Web of Science ®Google Scholar
• Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M, Goldblatt D, Kotoucek P, Thomas W, Lester W. Pathologic antibodies to platelet factor 4 after ChAdox1 nCov-19 vaccination. N Engl J Med. 2021;384(23):2202–11. doi:10.1056/NEJMoa2105385. PMID: 33861525.
   PubMed Web of Science ®Google Scholar
• Wise J. Covid-19: European countries suspend use of Oxford-ChAdox1 vaccine after reports of blood clots. BMJ. 2021;372:n699. doi:10.1136/bmj.n699.
   PubMed Web of Science ®Google Scholar
• GOV.UK. JCVI statement on use of the ChAdox1 COVID-19 vaccine. 2021 Apr 7. [cited 2022 Feb 22]. Available from: https://www.gov.uk/government/publications/use-of-the-ChAdOx1-covid-19-vaccine-jcvi-statement/jcvi-statement-on-use-of-the-ChAdOx1-covid-19-vaccine-7-april-2021.
   Google Scholar
• GOV.UK. JCVI advises on COVID-19 vaccine for people aged under 40, 2021 May 7th. [cited 2022 Feb 22]. Available from: https://www.gov.uk/government/news/jcvi-advises-on-covid-19-vaccine-for-people-aged-under-40.
   Google Scholar
• Cox DR. Regression models and life tables (with discussion). J Roy Stat Soc B. 1972;34:187–220.
   Web of Science ®Google Scholar
• Jones KH, Ford DV, Thompson S, Lyons RA. A profile of the SAIL databank on the UK secure research platform. Int J Popul Data Sci. 2019;4(2):1134. doi:10.23889/ijpds.v4i2.1134.
   PubMedGoogle Scholar
• Lyons RA, Jones KH, John G, Brooks CJ, Verplancke JP, Ford DV, Brown G, Leake K. The SAIL databank: linking multiple health and social care datasets. BMC Med Inform Decis Mak. 2009;9(1):3. doi:10.1186/1472-6947-9-3.
   PubMedGoogle Scholar
• Ford DV, Jones KH, Verplancke JP, Lyons RA, John G, Brown G, Brooks CJ, Thompson S, Bodger O, Couch T, et al. The SAIL databank: building a national architecture for e-health research and evaluation. BMC Health Serv Res. 2009;9(1):157. doi:10.1186/1472-6963-9-157.
   PubMedGoogle Scholar
• Lyons J, Akbari A, Torabi F, Davies GI, North L, Griffiths R, Bailey R, Hollinghusrt J, Fry R, Turner SL, et al. Understanding and responding to COVID-19 in Wales: protocol for a privacy-protecting data platform for enhanced epidemiology and evaluation of interventions. BMJ Open. 2020;10(10):e043010. doi:10.1136/bmjopen-2020-043010.
   PubMed Web of Science ®Google Scholar
• Clift AK, Coupland CAC, Keogh RH, Diaz-Ordaz K, Williamson E, Harrison EM, Hayward A, Hemingway H, Horby P, Mehta N. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ. 2020;371:m3731. doi:10.1136/bmj.m3731.
   PubMedGoogle Scholar
• COVID-19: the green book, chapter 14a. [accessed 2021 Oct 10th]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1037340/Greenbook-chapter-14a-30Nov21.pdf.
   Google Scholar
• COVID-19 vaccination first phase priority groups. [Accessed 2020 May 5th]. https://www.gov.uk/government/publications/covid-19-vaccination-care-home-and-healthcare-settings-posters/covid-19-vaccination-first-phase-priority-groups.
   Google Scholar
• Hippisley-Cox J, Patone M, Mei XW, Saatci D, Dixon S, Khunti K, Zaccardi F, Watkinson P, Shankar-Hari M, Doidge J. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ. 2021;374:n1931. doi:10.1136/bmj.n1931.
   PubMed Web of Science ®Google Scholar
• Taquet M, Husain M, Geddes JR, Luciano S, Harrison PJ. Cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 COVID-19 cases. EClinicalMedicine. 2021;39:101061. doi:10.1016/j.eclinm.2021.101061.
   PubMedGoogle Scholar
• Torjesen I. Covid-19: risk of cerebral blood clots from disease is 10 times that from vaccination, study finds. BMJ. 2021;373:n1005. doi:10.1136/bmj.n1005.
   PubMedGoogle Scholar
• Uaprasert N, Panrong K, Rojnuckarin P, Chiasakul T. Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials. Thrombosis J. 2021;19(86). doi:10.1186/s12959-021-00340-4.
   PubMedGoogle Scholar
• Simpson CR, Shi T, Vasileiou E, Katikireddi SV, Kerr S, Moore E, McCowan C, Agrawal U, Shah SA, Ritchie LD. First-dose ChAdox1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nat Med. 2021;27(7):1290–97. doi:10.1038/s41591-021-01408-4.
   PubMed Web of Science ®Google Scholar
• Pottegard A, Lund LC, Karlstad S, Dahl J, Andersen M, Hallas J, Lidegaard Ø, Tapia G, Gulseth HL, Ruiz PLD, et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdox1-S in Denmark and Norway: population based cohort study BMJ. BMJ (Clin Res Ed). 2021;373:1114. doi:10.1136/bmj.n1114.
   PubMed Web of Science ®Google Scholar
• EMA. COVID-19 vaccine ChAdox1: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets. 2021. March. https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots.
   Google Scholar
• Jaiswal V, Nepal G, Dijamco P, Ishak A, Dagar M, Sarfraz Z, Shama N, Sarfraz A, Lnu K, Mitra S, et al. Cerebral venous sinus thrombosis following COVID-19 vaccination: a systematic review. J Prim Care Community Health. 2022;13:21501319221074450. doi:10.1177/21501319221074450.
   Web of Science ®Google Scholar
• Palaiodimou L, Stefanou MI, Katsanos AH, Aguiar de Sousa D, Coutinho JM, Lagiou P, Michopoulos I, Naska A, Giannopoulos S, Vadikolias K, et al. Cerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: a systematic review and meta-analysis. Neurology. 2021;97(21):e2136–e2147. doi:10.1212/WNL.0000000000012896.
   PubMed Web of Science ®Google Scholar
• Hafeez MU, Ikram M, Shafiq Z, Sarfraz A, Sarfraz Z, Jaiswal V, Sarfraz M, Chérrez-Ojeda I. COVID-19 vaccine-associated thrombosis with thrombocytopenia syndrome (TTS): a systematic review and post hoc analysis. Clin Appl Thromb Hemost. 2021;27:10760296211048815. doi:10.1177/10760296211048815.
   Web of Science ®Google Scholar
• Palaiodimou L, Stefanou MI, de Sousa DA, Coutinho JM, Papadopoulou M, Papaevangelou V, Vassilakopoulos TI, Tsiodras S, Filippou DK, Tsivgoulis G. Cerebral venous sinus thrombosis in the setting of COVID-19 vaccination: a systematic review and meta-analysis. J Neurol. 2022;269(7):3413–19. doi:10.1007/s00415-022-11101-2.
   PubMed Web of Science ®Google Scholar